436 related articles for article (PubMed ID: 31340546)
1. Mesenchymal Stem Cells for Perianal Crohn's Disease.
Carvello M; Lightner A; Yamamoto T; Kotze PG; Spinelli A
Cells; 2019 Jul; 8(7):. PubMed ID: 31340546
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
[TBL] [Abstract][Full Text] [Related]
3. Cell-based Therapy for Perianal Fistulising Crohn's Disease.
Kotze PG; Spinelli A; Lightner AL
Curr Pharm Des; 2019; 25(1):41-46. PubMed ID: 31092172
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn's Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons.
Williams P; Klersy C; Karki C; Bennett D; Rodríguez AM; Ciccocioppo R
Adv Ther; 2022 Jun; 39(6):2761-2777. PubMed ID: 35426592
[TBL] [Abstract][Full Text] [Related]
5. Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn's disease.
Molendijk I; van der Meulen-de Jong AE; Verspaget HW; Veenendaal RA; Hommes DW; Bonsing BA; Peeters KCMJ
Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1148-1154. PubMed ID: 30095479
[TBL] [Abstract][Full Text] [Related]
6. Darvadstrocel for the treatment of perianal fistulas in Crohn's disease.
Meng ZW; Baumgart DC
Expert Rev Gastroenterol Hepatol; 2020 Jun; 14(6):405-410. PubMed ID: 32354239
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II clinical trial of ex-vivo expanded human bone marrow derived allogeneic mesenchymal stromal cells in adult patients with perianal fistulizing Crohn's Disease.
Swaroop S; Vuyyuru SK; Kante B; Kumar P; Mundhra SK; Arora U; Goyal A; Kandasamy D; Sharma R; Kabilan K; Kedia S; Dash NR; Ahuja V
Stem Cell Res Ther; 2024 May; 15(1):140. PubMed ID: 38745184
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series.
Cabalzar-Wondberg D; Turina M; Biedermann L; Rogler G; Schreiner P
Colorectal Dis; 2021 Jun; 23(6):1444-1450. PubMed ID: 33595166
[TBL] [Abstract][Full Text] [Related]
9. Management of patients with complex perianal fistulas in Crohn's disease: Optimal patient flow in the Italian clinical reality.
Spinelli A; Armuzzi A; Ciccocioppo R; Danese S; Gionchetti P; Luglio G; Orlando A; Rispo A; Rizzello F; Sofo L; Solina G; Poggioli G
Dig Liver Dis; 2020 May; 52(5):506-515. PubMed ID: 31901310
[TBL] [Abstract][Full Text] [Related]
10. A Phase I Study of Ex Vivo Expanded Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells for the Treatment of Pediatric Perianal Fistulizing Crohn's Disease.
Lightner AL; Otero-Pineiro A; Reese J; Ream J; Nachand D; Adams AC; VanDenBossche A; Kurowski JA
Inflamm Bowel Dis; 2023 Dec; 29(12):1912-1919. PubMed ID: 37263018
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease.
Castro-Poceiro J; Fernández-Clotet A; Panés J
Immunotherapy; 2018 Oct; 10(14):1203-1217. PubMed ID: 30296868
[TBL] [Abstract][Full Text] [Related]
12. Modern management of perianal fistulas in Crohn's disease: future directions.
Kotze PG; Shen B; Lightner A; Yamamoto T; Spinelli A; Ghosh S; Panaccione R
Gut; 2018 Jun; 67(6):1181-1194. PubMed ID: 29331943
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials.
Wang H; Jiang HY; Zhang YX; Jin HY; Fei BY; Jiang JL
Stem Cell Res Ther; 2023 Apr; 14(1):103. PubMed ID: 37101285
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and prognosis of children with perianal fistulizing Crohn's disease].
Fang YH; Luo YY; Zhang RF; Cheng Q; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jan; 26(1):42-47. PubMed ID: 38269458
[TBL] [Abstract][Full Text] [Related]
16. Cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn's disease.
Bislenghi G; Wolthuis A; Van Assche G; Vermeire S; Ferrante M; D'Hoore A
Expert Opin Biol Ther; 2019 Jul; 19(7):607-616. PubMed ID: 31121104
[No Abstract] [Full Text] [Related]
17. Stem Cell Therapy for the Treatment of Crohn's Disease; Current Obstacles and Future Hopes.
El-Nakeep S
Curr Stem Cell Res Ther; 2022; 17(8):727-733. PubMed ID: 34514993
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study.
Wei J; Zhang Y; Chen C; Feng X; Yang Z; Feng J; Jiang Q; Fu J; Xuan J; Gao H; Liao L; Wang F
Stem Cell Res Ther; 2023 Oct; 14(1):311. PubMed ID: 37904247
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the management of perianal fistulizing Crohn's disease: lessons for the clinic.
Lopez N; Ramamoorthy S; Sandborn WJ
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):563-577. PubMed ID: 31023087
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem-cell therapy for perianal fistulas in Crohn's disease: a systematic review and meta-analysis.
Cheng F; Huang Z; Li Z
Tech Coloproctol; 2019 Jul; 23(7):613-623. PubMed ID: 31286287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
